Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Teva
McKesson
Dow
US Army
US Department of Justice
Cantor Fitzgerald
Mallinckrodt

Generated: May 24, 2018

DrugPatentWatch Database Preview

PAMINE FORTE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pamine Forte, and when can generic versions of Pamine Forte launch?

Pamine Forte is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE FORTE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
Summary for PAMINE FORTE
Drug patent expirations by year for PAMINE FORTE
Pharmacology for PAMINE FORTE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Synonyms for PAMINE FORTE
(-)-Scopolamine methyl bromide
(1S,2R,4S,5S)-7-((3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
(1S,2R,4S,5S)-7-[(3-HYDROXY-2-PHENYLPROPANOYL)OXY]-9,9-DIMETHYL-3-OXA-9-AZATRICYCLO[3.3.1.0(2),?]NONAN-9-IUM BROMIDE
(1s,2r,4s,5s)-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide,(-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium,6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide, (-)-tropate
2660-04-0
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2S)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (1alpha,2beta,4beta,5alpha,7beta)-
6beta,7beta-Epoxy-3alpha-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide (-)-tropate
7-(3-Hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxo-9-azoniatricyclo-(3.3.1.0(2,4))nonane bromide
AC1L1S97
AC1Q1RGR
AKOS026749843
Ampyrox
Blocan
C18H24NO4.HBr
CTK4F8213
D04LHJ
Diopal
EINECS 205-844-5
Epoxymethamine bromide
Epoxytropine tropate methylbromide
HE019761
Holopon
HSDB 5420
Hyoscin methobromide
Hyoscin-N-methylbromid
Hyoscine methyl bromide
Hyoscine methylbromide
Lescopine bromide
LS-157838
Mescopil
Methoscopylamine bromide
Methscopolamine (Pamine)
METHSCOPOLAMINE BROMIDE
Methylscopolamine bromide
Methylscopolamine hydrobromide
N-Methylhyoscine bromide
N-Methylhyoscinium bromide
N-Methylscopolamine Bromide
N-Methylscopolammonium bromide
Neo-Avagal
NSC 120606
Nutrop
Pamine
Paraspan
PL044589
Proscomide
Restropin
SCHEMBL1652312
Scopolamin-N-methylbromid
Scopolamine methobromide
Scopolamine methylbromide
Scopolammonium, N-methyl-, bromide
SCOPOLAMMONIUM, N-METHYLBROMIDE
Scordin
U 0382

US Patents and Regulatory Information for PAMINE FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Farmers Insurance
Boehringer Ingelheim
US Department of Justice
Fish and Richardson
Fuji
Cerilliant
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.